// App-Quantinova.ai

1847 : Evaluating the metastatic potential and the molecular heterogeneity of patient-derived orthotopic xenograft models of triple-negative breast cancer

Researchers

Presenter

  • Vishnu C. Ramani

Principal Investigators

  • Gerald Quon

  • Melanie Triboulet

  • Corinne Renier

  • Cassandra Greene

  • Chad Sanada

  • Tracy Lu

  • Lukasz Szpankowski

  • Naveen Ramalingam

  • Ameen A. Salahudeen

  • Sean de la O

  • Ranjani Rajapaksa

  • Shoshana Levy

  • Anne A. Leyrat

  • Jay A. West

  • Elodie Sollier-Christen

  • Calvin J. Kuo

  • George W. Sledge

  • Stefanie S. Jeffrey

Medical Centers

  • University of California, Davis, CA

  • 3-V Biosciences Inc, Menlo Park, CA

  • Fluidigm Corporation, South San Francisco, CA

Locations

  • United States

Companies

  • Vortex Biosciences,

  • Fluidigm Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved